U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187882) titled 'Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo' on Sept. 16.

Brief Summary: To observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and providing a basis for clinical application.

Study Start Date: April 25, 2024

Study Type: INTERVENTIONAL

Condition: Vitiligo

Intervention: PROCEDURE: Autologous Non-cultured Epidermal Cell Suspension transplantation

1. Thin split thickness skin grafts were taken from...